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Introduction
Aging of the population and decreased cardiac care are associated with an increasing incidence and prevalence of heart failure (HF). HF is associated with high morbidity and mortality and imposes a significant economic burden on health systems. It is therefore necessary to evaluate the putative risk factors that may have predictive or causal relevance to the risk for HF and, by evaluating them, help tailor preventive and therapeutic interventions. Cardiorespiratory fitness (CRF) is a relatively new measure of assessing cardiac and respiratory functioning. During recent years, the assessment of CRF has achieved significant clinical merit and is considered to be a vital part of patient risk assessment. Directly measured maximal oxygen uptake ( 2max ), an objective and quantitative measure of CRF, is the gold standard for assessing the amount of oxygen consumption during exercise testing. 1, 2 In addition to systolic blood pressure (SBP) at rest, exercise-induced elevation of SBP has been found to be an independent predictor of hypertension, 3, 4 coronary heart disease, [5] [6] [7] cardiovascular disease, 8, 9 and sudden cardiac death. 10 Previous studies have shown that exercise cardiac power (ECP) predicts the risk of stroke, sudden cardiac death, and cardiovascular deaths. [11] [12] [13] Although, CRF is a key marker of cardiovascular capacity, it does not take into account the detailed differences in cardiovascular resistance and cardiac afterload between the subjects, whereas ECP does take these factors into consideration.
We therefore hypothesized that an index measure of ECP, defined as the ratio of directly measured 2max with peak SBP during exercise could give prognostic information on HF risk stratification. We investigated the association of ECP during exercise with the risk of HF in a population-based sample of men from eastern Finland.
Methods

Subjects
Subjects were participants in the Kuopio Ischaemic Heart Disease Risk Factor Study, which was designed to investigate risk factors for cardiovascular diseases (CVD), carotid atherosclerosis, and related outcomes in a population-based, randomly selected sample of men from eastern Finland. 12 Complete data on ECP was available on 2351 subjects with no history HF at baseline.
Assessment of ECP
A maximal symptom-limited exercise tolerance test was performed between 8:00 a.m. and 10:00 a.m. using an electrically braked cycle ergometer. 6 For safety reasons, all tests were supervised by an experienced physician with the assistance of an experienced nurse. An electrocardiogram, blood pressure, and heart rate were recorded during the exercise test. 10, 11 A week before the exercise test, between 8:00 a.m. and 10:00 a.m.,
the resting blood pressure of participants was measured after 5 min and 10 min of rest using a
Hawksley random zero muddler sphygmomanometer ( Hawksley & Sons Ltd., Lancing, UK).
An experienced nurse measured the blood pressure while participants were in a seated position in a quiet room. The mean value of the 2 blood pressure (after 5 min and 10 min of rest) was used as resting blood pressure. Resting hypertension was defined as hypertension confirmed by current use of antihypertensive medication and/or an SBP greater than 140mmHg and/or diastolic blood pressure (DBP) greater than 90mmHg. Immediately before the exercise phase (start), pre-exercise blood pressure was measured manually while the participant was sitting on the cycle ergometer (Tunturi EL 400; Tunturi New Fitness, Turku, Finland 
Assessment of other covariates
Body mass index (BMI) was computed as the ratio of weight in kilograms to the square of height in meters. Information on use of medications and diagnosis of diseases was collected at the baseline examination by an internist. 11 Alcohol consumption was assessed with the use of the Nordic Alcohol Consumption Inventory. Left ventricular hypertrophy (Sokolow-Lyon index) was recorded at rest. The collection of blood specimens and the measurement of serum lipids, serum lipoproteins, and insulin, as well as the definition of type 2 diabetes, have been described elsewhere. 10, 11 Serum C-reactive protein was measured with an immunometric assay (Immulite High Sensitivity C-reactive protein Assay; Diagnostic Products Corp., Los Angeles, CA, USA).
Ascertainment of incident HF events
All incident HF cases that occurred from the time of study enrolment (from March 1984 to December 1989) through 2014 were included. There were no losses to follow-up. 14, 15 All study (Fig. 1 ). The C-statistics index was calculated to assess the model discrimination, or the ability of the model to correctly identify subjects with respect to sudden cardiac death. 17 We also computed the net reclassification index (NRI), 18 which compares the shifts in reclassified categories by observed outcome.
Results
Baseline characteristics
At the beginning of the follow-up, the mean age of the subjects was 52.2 years (range: 42.0 years to 61.2 years). The mean ECP was 11.9 mL/mmHg (SD = 3.16 mL/mmHg, range: 3.39 mL/mmHg to 29.57 mL/mmHg). At baseline examination, men with low ECP were older; smoked more; had higher serum LDL cholesterol, SBP, and prevalence of diabetes; were less physically active; and had low serum HDL compared to those who had higher ECP (Table 1) .
Medications and some of the exercise parameters are shown in Table 2 . Subjects were divided into quartiles on the basis off ECP.
Risk predictors for HF
As continuous variables, the strongest statistically significant risk factors for HF were ECP (p < 0.001), smoking (p < 0.001), and type 2 diabetes (p = 0.001), after adjustment for age (Table   1 ). One SD increase in ECP (3.16 mL/mmHg) was associated with a decreased risk of HF by 28% (95%CI: 17%  37%).
ECP and risk for HF in men
ECP was associated with the risk of HF ( was treated as reference), and 5.2/1000 person-years, 6.8/1000 person-years, and 9.9/1000 person-years in the quartiles, respectively ( Table 3 ). The multivariate adjusted cumulative Kaplan Meier curves are shown in Fig. 1 . In a sensitivity analysis, we excluded 86 men who discontinued the test due to symptoms; an inverse association between ECP and HF risk remained significant.
ECP, SBP at rest, and the risk of HF
Among men with lowest ECP (<9.84 mL/mmHg) and normal resting SBP, a markedly increased HR of HF was observed (2.37-fold, 95%CI: 1.68  3.35, p < 0.001). Men with low ECP (<9.84 mL/mmHg) and elevated resting SBP (≥140 mmHg, median) had a markedly increased HR of HF. These men had a 1.71-fold (95%CI: 1.17  2.40, p = 0.004) increased HR compared to men with high ECP and low resting SBP. The HR was not markedly different in these sub-group analyses according to resting SBP level, and this may be related to the size of subgroups and number of outcomes.
ECP assessment and HF risk prediction
An HF risk prediction model containing established risk factors yielded a C-index of 0.708 (95%CI: 0.685 -0.731). After addition of information on ECP to the model, the C-index was 0.726 (95% CI: 0.704 -0.748). The continuous NRI changed 0.143% (95%CI: 0.109% -0.178%, p = 0 017), after inclusion of ECP with other risk factors.
The C-statistics index was calculated to assess the model discrimination, or the ability of the model to correctly identify subjects with respect to HF 17 We also computed the NRI, 18 which compares the shifts in reclassified categories by observed outcome.
Discussion
ECP was associated with an increased risk of HF in a population-based study of men. The integration of afterload and preload with 2max and peak SBP during an exercise test emphasizes the role of ergospirometry in the risk prediction of HF because it gives prognostic information in addition to that obtained by conventional methods, although it did not add additional information over 2max . The results highlight that ECP is an important determinant of HF risk but provides negligible improvement in risk prediction. However, there was a significant improvement in reclassification.
Little is known about the association between ECP and the risk for HF. Our study shows that ECP may provide prognostic information on HF risk prediction despite taking into account established risk factors such as smoking, lipids, hypertension, left ventricular hypertrophy, COPD, and diabetes. This study shows that significant risk of HF was observed among men with the lowest level of ECP. A continuous increase in ECP (3.16 mL/mmHg) corresponds to a 28% decrease in the risk for HF among these men. Thus, ECP may provide a valuable tool for the risk prediction for HF in the general population, although further studies are needed.
2max is considered to be the gold standard for measuring cardiorespiratory fitness. In addition to 2max , SBP can be measured more reliably during cycle ergometry (as was done in our study) than with a treadmill due to the reduced upper body movements during the exercise.
It has been suggested that 2max is a non-invasive measure of cardiac output during physical stress and reflects cardiac preload, whereas SBP is a mere indicator of afterload during exercise because cardiac output is dependent both on preload and afterload. In subjects with elevated adrenergic tone and inappropriately constricted arterial bed, cardiac output can be lowered in the presence of disproportionately elevated SBP (i.e., afterload). 19, 20 Consequently, 2max may be reduced considerably over the years, and thus it may underestimate cardiac pumping capacity in subjects. Cardiac output is a non-invasive descriptor of cardiac function derived from preload, blood pressure, and left ventricular function. 21 It is probable that the incidence of HF can be reduced by a combination of several approaches, thus preventing its occurrence.
2max may be preserved among subjects with anti-hypertensive medications lowering afterload despite the reduced pumping capacity.
Anti-hypertensive medications may decrease the afterload and increase cardiac output to a higher level during progressive exercise. This was not the case in our study, since we adjusted for anti-hypertensive medications but the results were still significant. 2max is determined by several physiological, environmental, and genetic factors, such as age, sex, physical activity, and prevalent diseases. Cardiorespiratory fitness can be improved by increasing physical activity, which ultimately confers long-term benefits on the cardiovascular system.
Physical inactivity leads to elevated levels of blood pressure, serum lipids, insulin resistance, and obesity, all of which may predispose an individual to the development of HF. Elevated levels of C-reactive protein have been implicated with an increased risk of HF, and there is a possibility that the association between improved CRF and reduced risk of HF might be mediated through the anti-inflammatory effects of physical activity. In addition to modifying serum cholesterol levels, exercise training may also affect the risk of nonfatal cardiovascular events through other pathways. [21] [22] [23] Lower levels of physical activity are associated with endothelial dysfunction, which may contribute to pre-clinical atherosclerosis. In subjects with preclinical atherosclerotic changes and elevated SBP increases, the stress on the vessel wall may lead to the risk of both endothelial injury and permeability, which may result in local or multifocal oedema. 2022, 24 However, additional research, including exercise intervention trials, would help discover the mechanistic pathways through which ECP plays a role in risk stratification. Previous studies have suggested that low cardiorespiratory fitness is comparable with other conventional risk factors for CVD. 7,10,25,26 A strong, inverse, and independent association between cardiorespiratory fitness and HF risk that is consistent with a doseresponse relationship has been observed in previous studies. 27 Our findings suggest that ECP may be used as an additional prognostic measure for HF in addition to 2max .
The strengths of this study are that we used a representative population-based sample of middle-aged men and had a high participation rate. There were no losses during follow-up, and reliable assessments of incident HF events were made. Other strengths include the definitive diagnosis of HF cases. The mean follow-up time of more than 25 years was sufficiently long to ascertain the risk for HF. We adjusted for a comprehensive panel of lifestyle and biochemical markers to allow adequate adjustment for potential confounding, enabling reliable assessments of the associations.
Some limitations of the present study also deserve mention. Participants were prospectively monitored using established databases for hospital admissions, which was supplemented with reliable data on health status and risk factors, thus permitting the control of potential confounders. Though we adjusted for several confounders, there may be a possibility of residual confounding due to other unmeasured confounders, which could in part explain the association between ECP and HF. The availability of more advanced cardiac imaging modalities to define better descriptors of cardiac function is a valuable asset in clinical studies, but cost tends to be a limiting factor in population-based studies. Not all participants had echocardiography performed at baseline; hence, there is the possibility that participants with prevalent structural heart disease may have been included in the analysis. We were unable to assess the differential impact of ECP on the risk of HF with preserved vs. reduced ejection fraction because we had no data on the ventricular function post HF development. Furthermore, using a cycle ergometer with a regular increase in the workload may not be the best way to evaluate maximal functional capacity in deconditioned people, and it could underestimate functional capacity in a subgroup of the population. It may be more difficult to measure blood pressure using a treadmill test compared to a cycle ergometer (without upper arm movements).
Another limitation of this study is that it is based on an ethnically homogenic and middleaged male population and cannot be extrapolated to women or other ethnicities. Differences in peak SBP are relatively small as compared to the differences in 2max . Consistent with the previous studies, the role of 2max seems to be still very important in the assessment of the risk of HF.
Conclusion
This prospective population-based study provides the first evidence that ECP is associated with an increased risk of HF. Abbreviations: ECP = exercise cardiac power; Q = quartile, 2max = maximal oxygen uptake. Abbreviations: CI = confidence interval; ECP = exercise cardiac power; HR = hazards ratio; HDL = high-density lipoprotein; LDL = low-density lipoprotein; Q = quartile. Graphic abstract
Figure legends
